Background: Juvenile polyps are distinct hamartomatous malformations of the gastrointestinal tract that may occur in the heritable juvenile polyposis syndrome (JPS) or sporadically. Histologically, juvenile polyps are characterized by a marked increase of the stromal cell compartment, but an epithelial phenotype has also been reported. JPS has an increased risk of colorectal cancer but sporadic juvenile polyps do not. In 50% to 60% of patients with JPS, a germline mutation of the transforming growth factor-b/bone morphogenetic protein (BMP) pathway genes SMAD4 or BMPR1A is found. This study compares the histologic phenotype of juvenile polyps with a SMAD4 or BMPR1A germline mutation and sporadic juvenile polyps.
J uvenile polyposis syndrome (JPS) is a rare autosomal dominant disorder that is characterized by the presence of multiple juvenile polyps in the gastrointestinal tract. Patients present during the first or second decade of life and have a markedly increased risk of colorectal cancer at a later age. 5, 7, 9 Clinical diagnosis is made when any 1 of the following criteria is met: (1) more than 3 to 5 juvenile polyps in the colorectum; (2) juvenile polyps throughout the intestinal tract; or (3) any number of juvenile polyps in combination with a positive family history of JPS. 9, 19, 25 Sporadic juvenile polyps are a more common finding, occurring in up to 2% of the pediatric population, and are considered as benign solitary lesions of the colorectum. 10, 19 Juvenile polyps most often have a spherical appearance with extensive surface erosion, a marked increase of the stromal cell compartment, inflammatory and reactive changes of the epithelium, and distorted and dilated crypts. Several studies have noticed a more lobulated and epithelial phenotype in a subset of juvenile polyps. 19 In 50% to 60% of patients with JPS, a germline defect in SMAD4 or BMPR1A of the transforming growth factor (TGF)-b/bone morphogenetic protein (BMP) signaling pathway, is found. 16, 17, 28 Inactivation of these genes in mice leads to a JPS-like phenotype. Smad4-mutant mice develop gastrointestinal polyps that are characterized by elongated and dilated tubular structures lined by a hyperplastic or serrated epithelium and a moderate expansion of the stromal cell compartment. Although mostly hyperplastic, the epithelium may show some atypia with occasional foci of dysplasia. 15, 27 In Bmpr1a-mutant mice, polyps had cystically dilated and distorted glands filled with mucin and inflammatory cells surrounded by fibrous stroma. 14 Moreover, inhibition of BMP signaling in mice (by transgenic expression of noggin, a BMP inhibitor, under control of a villin promoter) leads to branching and budding of the intestinal epithelium, crypt dilatation, and reactive inflammatory changes. At later stages, these mice develop foci of dysplastic epithelium and adenomatous change. 13 All these mouse models show features reminiscent of JPS; however, differences may exist in the phenotype depending on the genetic background. In this study, we compared the histologic phenotype of human juvenile polyps with a SMAD4 or BMPR1A germline mutation and sporadic juvenile polyps. In addition, the possible role of the conventional adenoma-carcinoma sequence in the neoplastic progression in JPS was evaluated.
METHODS

Patients and Tissue
Archival material from patients with 1 or more juvenile polyps was collected from The Johns Hopkins Polyposis Registry and clinic (Baltimore, MD) and 2 academic hospitals in the Netherlands (Academic Medical Centre, Amsterdam, and University Medical Centre, Utrecht). The study was carried out according to the guidelines and with approval of the ethics committee of these institutions. Clinical and family history data were examined, and polyps were carefully reviewed by an experienced GI pathologist (G.J.A.O.) to confirm the diagnosis of JPS or sporadic juvenile polyps. All patients with JPS were analyzed for germline defects of SMAD4, BMPR1A, PTEN, ENG, and TGFBRII through direct sequencing and multiplex ligation-dependent probe amplification. 6, 28 Thirty-nine patients (90 polyps) were included in this study, including 8 patients (21 polyps) with a SMAD4 germline defect, 6 patients (44 polyps) with a BMPR1A germline defect, and 25 sporadic juvenile polyps.
Histologic Characterization
Hematoxylin and Eosin-stained slides of all juvenile polyps were systematically scored for individual histologic features possibly associated with juvenile polyps (ie, crypt distortion and dilatation, crypt density, stromal expansion, surface erosion, inflammatory and reactive change of the epithelium, vascular proliferation, Paneth cell metaplasia, thickening of the basal membrane, and eosinophilia). Evaluation showed 2 general phenotypes, namely that of a classic juvenile polyp comprising a prominent stromal compartment, dilated glands, and surface erosion, and polyps with a predominantly epithelial phenotype (Figs. 1A, B). Several features best describing the encountered phenotypes were then grouped together creating 2 categories as is shown in Table 1 . Subsequently, all polyps were classified according to these 2 categories. If polyps showed heterogenic or intermediate features, overall crypt density served as the decisive and most discriminatory feature. In addition, all polyps were graded for dysplasia according to the standard criteria. 11 
Count Stereology
To better appreciate our histologic findings, a quantitative evaluation of crypt density was made. A crypt-stroma ratio was determined by means of count stereology on Hematoxylin and Eosin-stained slides of all juvenile polyps. Using the Q-prodit software, fields of vision were systematically distributed throughout the entire polyp at a Â 10 magnification. An overlying 4-point Weibel grid was used to score epithelial or stromal counts. A discriminator of 1.00, describing equal counts of stroma and epithelium, was chosen arbitrarily to determine the predominant feature. A ratio <1.00 indicating a low crypt density was designated type A and a ratio Z1.00 was designated type B. All polyps were categorized according to these criteria, and results were compared with the histologic classification.
Immunohistochemistry and Scoring
Tissues were formalin-fixed and paraffinized in accordance with standard procedures. Immunohistochemistry was performed using a monoclonal antibody for Ki67 (DAKO MIB-1, Cat.no. M7240, 1:200). In brief, 4-mm sections were deparaffinized and blocked for endogenous peroxidase activity by immersion in 0.3% H 2 O 2 in methanol for 20 minutes. Antigen retrieval was performed in Tris/ethylenediaminetetraacetic acid buffer (10 mM/1 mM; pH 9.0) for 10 minutes at 1201C. Nonspecific binding sites were blocked in phosphate buffered saline with 10% normal goat serum for 10 minutes, followed by antibody incubation for 1 hour at room temperature. Antibody binding was visualized using the Powervision and poly-HRP detection system (Im-munoVision Technologies, Co, Daly City, CA) with 3,3diamino-benzidine (Sigma D5637) as the chromogen. The slides were counterstained with hematoxylin.
Ki67 is a nuclear proliferation marker expressed during all phases of actively growing cells but not in quiescent cells. Normal colon mucosa shows a distinctive nuclear Ki67 staining pattern with positive cells limited to the bottom third of the crypt, which is the proliferative compartment. Although in juvenile polyps the glands are often distorted, proliferative activity may remain confined to a restricted crypt compartment underneath the adjacent differentiatedFnonproliferativeFepithelium, thus retaining a compartmentalized phenotype. Loss of compartmentalization was defined as an overall increase in proliferative cells and the dissemination thereof throughout the epithelium resulting in loss of a clear distinction between the proliferative zone and the overlying differentiated epithelium. The slides were scored in a dichotomous manner describing retention or loss of compartmentalization, the latter indicating an expansion of cell cycle activity.
Statistical Analysis
Statistical analysis was carried out using the SPSS 15.0 software package. The w 2 test was used to determine whether correlation between phenotypes and Ki67 expression were statistically significant at a P value <0.05.
Laser Microdissection and DNA Isolation
Dysplastic epithelium was manually isolated from 8-mm sections counterstained with hematoxylin. DNA was obtained using TK buffer [400 mg/mL of proteinase K and 0.5% Tween 20, 50 mmol/L Tris (pH 9), 1 mmol/L NaCl, 2 mmol/L ethylenediaminetetraacetic acid]. After overnight incubation in 50 mL TK buffer at 561C, proteinase K was inactivated through incubation at 951C for 10 minutes. 4 APC and K-ras Mutation Analysis APC and K-ras mutation analysis was carried out through polymerase chain reaction amplification using Platinum Taq DNA Polymerase (Invitrogen Corporation, Carsbad, CA) of DNA samples. For APC, 4 specific primer sets covering the mutation cluster region in exon 15 were used (1For-GAAATAGGATG TAATCAGACG, 1Rev-CGCTCCTGAAGAAA ATTCAAC, 2For-ACTG CAGGGTTCTAGT TTATC, 2Rev-GAGCTGGCAAT CGAACGA CT, 3For-TACTTCTGTCAGTTCACTTG A TA, 3Rev-ATTTTTAGGTACTTCTCGCTTG, 4For-A AACACCTCCACCACCTCC, 4Rev-GCATTATTCTT AATTCCACATC). 24 Amplification was performed at a T m of 551C for primer sets 1, 2, and 3, and at 581C for primer set 4. Two primer sets were used for K-ras mutation analysis for exons 1 and 2, in which mutational hotspot codons 12, 13, and 61 are located (Exon1 For-CTG GTGGAGTATTT GATAGT, Exon1 Rev-ATG GTCC TGCACCAGTAATA, Exon2For-GTGCACTGTAATA A TCCAGAC, Exon2 Rev-CCACCTATAATGGTGAA TATCT). 8 Sequencing was conducted using the ABI Prism 3130 genetic analyzer.
RESULTS
Histologic Characterization
Two categories of individual features were created to best describe the 2 phenotypes encountered on initial evaluation of the slides, namely the classical and the epithelial type juvenile polyps (Table 1) (Figs. 1A, B ). All polyps were classified according to these 2 categories. Intermediate features notwithstanding, a dichotomous decision with regard to juvenile polyp phenotype was always rendered with crypt density serving as the decisive feature. The phenotype described as classic juvenile polyp was found in 39 of 65 (60%) JPS polyps, and the epithelial variant was found in 26 of 65 (40%) polyps. The epithelial variant was more common in polyps with a SMAD4 germline mutation compared with polyps with a BMPR1A germline mutation (P<0.001) ( Table 2 ). All the 25 sporadic juvenile polyps were of the classic phenotype.
Crypt-Stroma Ratio
Crypt density was considered as the most discriminatory factor in differentiating between the classic juvenile polyp and the epithelial-type juvenile polyp based on initial evaluation of the earlier mentioned features. To better appreciate our histologic findings, a quantitative evaluation of crypt density was made. Systematic random crypt and stroma counts were obtained by stereologic methodology to determine a crypt-stroma ratio ( Fig. 2A) . The crypt-stroma ratio was significantly higher in juvenile polyps with a SMAD4 germline mutation compared with those with a BMPR1A germline mutation (P = 0.001) (Fig. 2B ). Juvenile polyps with a BMPR1A germline mutation had a higher ratio than sporadic juvenile polyps (P<0.001).
A crypt-stroma ratio <1.00 was designated type A referring to the classic juvenile polyp category, and a ratio Z1.00 was called type B specifying the epithelial variant. According to these criteria, 38 of 65 JPS polyps were of type A (58%) and 27 were of type B (42%). Classification according to crypt-stroma ratio confirmed the observations made on histologic evaluation that the epithelial variant (type B polyp) is more frequently found in patients with a SMAD4 germline mutation compared with individuals with a BMPR1A germline mutation (P<0.05) ( Table 2 ). In 8 JPS polyps, of which 3 had a SMAD4 germline mutation and 5 had a BMPR1A germline mutation, histologic classification did not concur with stereologic findings (Figs. 1C, D) . With regard to the sporadic juvenile polyps, all but 1 were classified as type A.
Dysplasia
All polyps were graded for dysplasia. The frequency in which different grades of dysplasia were seen was similar for polyps with either a SMAD4 or BMPR1A germline mutation (Table 3 ). However, evaluation by the polyp type showed a distinct pattern of dysplasia in polyps with a SMAD4 or BMPR1A background. Focal dysplasia in a SMAD4 setting was found only in type B polyps, but in a BMPR1A setting focal dysplasia was seen in both type B and type A polyps ( Table 4 ). All sporadic polyps were negative for dysplasia.
Immunohistochemistry
To investigate whether variations in crypt density in juvenile polyps could be attributed to differences in proliferative activity, immunostaining of the Ki67 proliferation marker was performed. Focal loss of compartmentalization of Ki67 indicating expanded cell cycle activity was observed in 12 of 21 (57%) juvenile polyps with a SMAD4 germline mutation and in 25 of 44 (57%) juvenile polyps with a BMPR1A germline mutation. Evaluation of the immunostaining per polyp type per germline defect showed a correlation between a B phenotype and focal loss of Ki67 compartmentalization especially in juvenile polyps with a SMAD4 germline mutation (P = 0.006), but not in those with a BMPR1A mutation (P = 0.131) ( Table 5 ). However, when stratified by the presence or absence of dysplasia, no correlation between decompartmentalization of Ki67 and the B phenotype was seen in juvenile polyps with either a SMAD4 (P = 1.000) or BMPR1A (P = 0.668) germline mutation. Focal loss of compartmentalization was found in 2 sporadic juvenile polyps.
APC and K-ras Mutation Analysis
To explore the role of the conventional adenomacarcinoma sequence in the development of neoplastic change in patients with JPS, APC and K-ras mutation analysis was carried out. Only those polyps graded for dysplasia were analyzed. Of the 16 tissues available, 2 polyps showed a K-ras point mutation in exon 1 (GGT-GAT). The K-ras mutations were found in areas of lowgrade dysplasia in 1 type A polyp from a patient with a germline BMPR1A mutation and in 1 type B polyp from a patient with a SMAD4 germline mutation. None of the polyps showed a mutation in the mutation cluster region of the APC gene (data not shown). In addition, 10 nonsyndromic juvenile polyps were found to be negative for K-ras mutation.
DISCUSSION
JPS is caused by a germline defect in SMAD4 or BMPR1A. 16, 17 Transgenic mice develop distinct JPS-like phenotypes depending on which of the JPS-causing genes are targeted. Smad4-mutant mice show hyperplastic or serrated epithelium and minor stromal overgrowth, whereas Bmpr1a-mutant mice or mice with inhibited BMP signaling through transgenic expression of noggin show polyps with reactive changes of the epithelium, crypt dilatation, and a prominent stromal compartment. [13] [14] [15] 27 We investigated and compared the histologic phenotype of human juvenile polyps from patients with a SMAD4 or BMPR1A germline mutation.
Consistent with earlier reports, histologic evaluation showed a subset of JPS polyps featuring an epithelial phenotype (40%), deviating from classic juvenile polyps characterized by a prominent stromal compartment (60%). 10, 19 The epithelial phenotype was more prevalent in cases with a SMAD4 germline mutation, whereas juvenile polyps with a BMPR1A germline mutation predominantly had the classic juvenile polyp phenotype (P<0.001).
Interestingly, quantitative evaluation of the cryptstroma ratio confirmed our initial histologic findings. Juvenile polyps with a SMAD4 germline mutation had a significantly higher crypt-stroma ratio compared with those with a BMPR1A germline mutation indicating a higher crypt density in the former and confirming the epithelial phenotype. These results underscore the relevance of crypt density as discriminatory feature between the classic and epithelial-type juvenile polyps.
Nevertheless, 8 JPS polyps showed a discrepancy between histologic and stereologic classification, and may thus be considered to show intermediate features (Figs. 1C, D) . Reevaluation of these polyps showed that massive crypt dilatation may result in a juvenile polyp initially labeled as a classic phenotype to be considered as a B-type polyp by stereologic means. In contrast, surface erosion and subsequent inflammation in juvenile polyps with a proliferative core may cause a polyp to be classified histologically as an epithelial phenotype that is yet to be stereologically scored as type A.
Similar frequencies of indefinite, low-grade and highgrade dysplasias were found in juvenile polyps from patients with either a SMAD4 or BMPR1A germline defect, contradicting earlier reports of a more dysplasia-prone FIGURE 2. Crypt-Stroma ratio. Crypt and stroma counts as obtained by systematic random count stereology (A) and the cryptstroma ratio showed by the genetic background (B). Juvenile polyps with a SMAD4 germline defect had a significantly higher crypt-stroma ratio compared with juvenile polyps with a BMPR1A germline defect (P = 0.001). intestinal phenotype in polyps with a SMAD4 germline mutation. 12, 26 Interestingly, 50% of all foci of low-grade or high-grade dysplasia in juvenile polyps with a BMPR1A germline defect were found in type-A polyps, whereas none of the type-A polyps with a SMAD4 germline defect contained dysplasia.
To investigate whether the neoplastic change in the juvenile polyps could be attributed to mutations in the conventional adenoma-carcinoma sequence, the dysplastic areas were investigated for APC and K-ras mutations. Our results showed only 2 polyps with K-ras mutations. Consequently, earlier reports of APC mutations in dysplastic polyps 31 could not be confirmed. These data suggest that the conventional adenoma-carcinoma sequence may not play a distinct role in JPS tumor formation, as has been concluded by other investigators. 32 Moreover, the different phenotypes could not be attributed to either an APC or K-ras mutation. Evaluation of the Ki67 proliferation marker demonstrated that focal loss of compartmentalization of Ki67 that expanded cell cycle activity, could not be linked to an A or B phenotype when stratified by dysplasia. This finding is consistent with the concept that loss of compartmentalization of the proliferative zone is a general feature of dysplasia regardless of the underlying genetic defect.
Few earlier studies have been dedicated to the evaluation of a relationship between genetic makeup and histologic phenotype in juvenile polyps. Handra-Luca et al 12 analyzed a series of juvenile polyps for percentage and morphology of epithelial and stromal components, blood vessels, level of inflammation, hyperplasia, and dysplasia. They characterized several distinctive features of polyps with a SMAD4 mutation: association with various grades of dysplasia, upper digestive tract location, and malformative vessels in the stroma. BMPR1A polyps were exclusively of the lower digestive tract and were not associated with dysplasia or malformative vessels. As mentioned, our results showed no distinction with regard to presence and/or grade of dysplasia between juvenile polyps in the setting of a SMAD4 or BMPR1A germline mutation. Although presence of vascular malformation was evaluated in the initial screening, it was not a discriminatory feature in our series of juvenile polyps (data not shown). No polyps of the upper digestive tract were present in our cohort.
In addition, Aretz et al 1 described various histologic phenotypes ranging from juvenile polyps to hyperplastic polyps and pseudopolyps, albeit with adenomatous components, or even adenomas in juvenile polyposis patients with an established germline mutation in one of the associated genes; however, no correlation between genotype and histologic phenotype is provided. Nevertheless, our results confirm the wide array of histologic phenotype variations encountered in the setting of juvenile polyposis.
SMAD4 and BMPR1A are both key components of the TGF-b/BMP signaling pathway maintaining homeostasis of the intestinal lining through processes of cellular proliferation (TGF-b) and differentiation and apoptosis (BMP). Signal transduction takes place through phosphorylation of the type-1 transmembrane receptor kinase (ie, BMPR1A) by the type-2 receptor. The activated type-1 receptor phosphorylates the pathwayrestricted SMAD2 and SMAD3 (TGF-b) or SMAD1, SMAD5, and SMAD8 (BMP), which, in complex with the common mediator SMAD4, is translocated to the nucleus where target gene transcription is regulated. 23 Individuals with germline defects in SMAD4 or BMPR1A and consequent disrupted TGF-b/BMP signaling develop multiple hamartomatous malformations in the gastrointestinal tract. These hamartomas are often characterized by an abnormal stromal component suggesting a prominent role for the stroma in polyp formation. The polyp epithelium initially shows normal maturation, although inflammation is common and may cause reactive changes. Subsequent dysplastic progression of the epithelium has been proposed to be the result of the altered microenvironment. 21 Recent studies provide evidence that conditional inactivation of Bmpr2 in the intestinal mesenchyme leads to mice developing hamartoma-like polyps, whereas conditional deletion of Bmpr1a in the epithelium showed elongation of the villi, but no de novo crypt or polyp formation. 2, 3 Consistent loss of heterozygosity (LOH) of the BMPR1A locus has thus far not been detected in the epithelium or stroma of JPS polyps from patients with a BMPR1A germline mutation, 17 although 1 study reports somatic loss of the 10q22 region exclusively in the lamina propria and not in the epithelium suggesting that inactivation of BMPR1A might be a stromal event. 18 Selective loss of Smad4-dependent signaling in T cells leads to a JPS-like phenotype reminiscent of what we described as a type-A polyp with cystic spaces lined by columnar epithelium surrounded by abundant stroma. 20 Smad4 heterozygous mice in contrast develop polyps with an epithelial phenotype (type B) and show LOH specifically in the epithelium of larger polyps. 27, 32 Similarly, LOH of the SMAD4 locus occurs in the epithelium of juvenile polyps from patients with a SMAD4 germline mutation. 22, 29 The exact role of SMAD4 and timing of SMAD4 inactivation in polyp initiation and progression remain poorly understood, but it seems that these polyps develop mainly through an epithelial defect. 22, 30 In addition to phenotype classification, SMAD4 immunohistochemistry may provide a specific marker for the detection of a SMAD4 germline mutation. 22 Although the number of polyps in this study is limited, we propose that juvenile polyps with a SMAD4 germline defect have a higher crypt density regardless of the dysplastic status. On the contrary, juvenile polyps with a BMPR1A defect are more often classic juvenile polyps with a prominent stromal compartment. Crypt density in these polyps is initially low but may increase due to neoplastic change of the epithelium. Investigation of Ki67 immunohistochemistry shows that the difference in crypt density in juvenile polyps with a SMAD4 or BMPR1A germline mutation is not a result of altered proliferative activity. We conclude that juvenile polyps in the setting of JPS may exhibit distinct phenotypes. Juvenile polyps with a SMAD4 germline mutation more likely express an epithelial phenotype with a relatively high crypt density, whereas juvenile polyps with a BMPR1A mutation are usually the classic juvenile polyp phenotype with a prominent stromal compartment. Importantly, we find similar rates for all grades of dysplasia in juvenile polyps with either a SMAD4 or BMPR1A background.
